R&D Turning the NHS into a world-leading R&D platform Lord James O'Shaughnessy sets out the basis of his forthcoming independent review.
R&D Future of generative AI in pharma Talk of implementing automation and AI to enhance human capacity is dominating conversations.
R&D Why life sciences companies need to engage with Labour now Lexington senior counsel Ben Nunn discusses the opposition party leader's mission statement.
Oncology Better balance of cancer treatment efficacy and toxicity The FDA Oncology Center of Excellence announced its Project Optimus draft guidance in January.
R&D JP Morgan 2023 – Joe Spinelli Editor-in-chief Jonah Comstock chats virtually with Aranscia's Joe Spinelli.
R&D JP Morgan 2023 – Lisa Yañez At JP Morgan Week, pharmaphorum caught up with Lisa Yañez, CEO of Aerami Therapeutics.
News BridgeBio gains on phase 3 dwarfism data Shares in BridgeBio rose after it revealed data from a trial of infigratinib in achondroplasia, raising the prospect of the first oral treatment.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
